Hitachi, Sophia Genetics partner on genomics

By The Science Advisory Board staff writers

March 26, 2021 -- Hitachi and Sophia Genetics are joining forces to bring clinical, genomic, and real-world insights to healthcare providers as well as pharmaceutical and biopharmaceutical companies.

Under the long-term collaboration, the two firms will focus on data-driven precision medicine through the global commercial expansion and development of Hitachi's digital healthcare products, such as its molecular tumor board support service, and Sophia's Data-Driven Medicine (DDM) technology.

DDM is a cloud-based software-as-a-service that uses artificial intelligence (AI) and machine learning to generate insights for clinicians and researchers from multimodal datasets. Those insights lead to improved diagnosis, treatment, and drug development, Sophia said.

In the long run, the two companies will partner on research and development-related new products, they added.

Promega launches benchtop CE DNA analyzer
Promega has debuted Spectrum Compact CE, a benchtop capillary electrophoresis (CE) instrument.
The Role of Microscopy in Surface Science
Surface science technologies include instruments involved in analyzing and observing the chemical and physical surface properties of a material, especially...

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter